Cell-to-Cell Communication: How Microparticles Act as Messengers in the Body
"Unlocking the potential of microRNA signals for innovative therapies and diagnostics."
In the intricate world of cellular biology, communication is key. Cells constantly exchange information to coordinate functions, respond to stimuli, and maintain overall health. One fascinating method of cell-to-cell communication involves microparticles (MPs), tiny vesicles released by cells that act as messengers, carrying a variety of bioactive substances, including microRNAs (miRNAs).
MicroRNAs are small RNA molecules that play a crucial role in regulating gene expression. They can influence a wide range of cellular processes, including cell growth, differentiation, and apoptosis. When MPs transport miRNAs from one cell to another, they can alter the recipient cell's behavior and function.
Recent research has shed light on the significant role of platelet MPs in delivering a specific miRNA, miRNA-126-3p, to macrophages. This delivery modifies the macrophages' transcriptome (the complete set of RNA transcripts) and secretome (the collection of secreted proteins) and stimulates their phagocytic activity, which is essential for clearing cellular debris and pathogens. Understanding this intercellular communication could unlock new possibilities for diagnostic and therapeutic interventions.
Measurement Without a Standard
Microparticles and exosomes are smaller than conventional detection methods can reach, which complicates their isolation, detection, and characterization. Both sources report that no standardized procedures or measurement method are available. This leaves researchers without a common standard for assessing these submicron vesicles.
From “Platelet Dust” to Cell Communication
Peter Wolf first identified microparticles in 1967 during research on blood coagulation, describing them as a product of platelets and naming them “platelet dust.” Microparticles are submicron vesicles shed from a variety of cells. The 2013 review notes that microparticles of healthy origins contribute to intercellular communication and coagulation events that support bodily homeostasis.
How Do Microparticles Change Macrophage Behavior?
Macrophages, as key players in the immune system, are responsible for engulfing and digesting foreign particles, cellular debris, and pathogens. MPs, particularly those derived from platelets, interact significantly with macrophages. In fact, macrophages are largely responsible for clearing MPs from the body.
- Transcriptome and Secretome Modification: The introduction of miRNA-126-3p causes substantial changes in the macrophage's genetic machinery, leading to differential expression of 66 miRNAs and 653 RNAs.
- Enhanced Phagocytosis: The reprogramming of macrophages via platelet MPs pushes them towards a more active phagocytic phenotype, improving their ability to clear debris.
Challenges in Establishing Function
A critical systematic review of extracellular-vesicle clinical trials reports that most characterization relied on bulk EV isolates, while only 11% of studies used EV subpopulations in their experimental design. An ISEV position paper describes additional obstacles, including EV purity, biases in RNA-sequencing methods, and heterogeneity in EV RNA content. It concludes that current methods make it difficult to provide undisputable evidence that RNA mediates EV-induced effects.
The Future of Microparticle Research
Despite significant progress, several questions remain about the intricacies of MP research. The specific determinants and regulatory factors that govern miRNA sorting and packaging into MPs are still not fully understood. Similarly, the precise targets and functions of transferred miRNAs, as well as the molecular mechanisms involved in their action within target cells, require further investigation.
Design and Outstanding Questions
A review of biomaterial microparticles in contact with cells and tissues highlights innovative particle design and applications as future directions, while excluding internalization studies. A 2023 review of extracellular vesicles and nanoparticles describes recent advances and identifies major outstanding questions. It also notes that cells communicate by secreting signaling molecules, including proteins, lipids, and nucleic acids.
Particle Design and Drug Delivery
Biomaterial microparticles can be considered in the context of how particles interact with cells and tissues, with reviews emphasizing innovative design and applications. Cell-mediated delivery of synthetic nano- and microparticle-based drug carriers is described as a promising strategy for improving control over drug distribution and targeting. Together, these sources frame particle design and delivery as important areas for further development.
Communication, Cancer, and Drug Monitoring
Cell-derived microparticles, once considered cellular waste, are described as important to cellular processes and intercellular communication. The cited source also identifies them as major participants in cancer progression. Separately, a 2023 study reports a cell-chip device designed to monitor drug release from drug carriers in real time, integrating cell culture, real-time analysis, and drug-delivery tests.
However, unraveling these processes, especially the unique miRNA signatures within MPs and exosomes, presents a promising avenue for developing new diagnostic biomarkers. The ability to customize vesicles with specific sets of miRNAs opens the door to manipulating miRNA signals, potentially leading to innovative therapeutic strategies.
By understanding how cells communicate through microparticles and miRNAs, we can develop targeted therapies that address a wide range of diseases, from cardiovascular disorders to immune system dysfunctions. Further exploration in this field holds immense promise for improving human health.